QCI Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-235,992
Closed -$17.6M 262
2020
Q1
$17.6M Sell
235,992
-59,311
-20% -$4.1M 1.72% 24
2019
Q4
$19.2M Buy
295,303
+294,877
+69,220% +$19.2M 1.66% 29
2019
Q3
$27K Buy
426
+170
+66% +$11.1K ﹤0.01% 327
2019
Q2
$17K Sell
256
-53
-17% -$3.49K ﹤0.01% 394
2019
Q1
$20K Buy
309
+53
+21% +$3.52K ﹤0.01% 373
2018
Q4
$16K Hold
256
﹤0.01% 384
2018
Q3
$20K Sell
256
-100
-28% -$7.55K ﹤0.01% 372
2018
Q2
$25K Sell
356
-200
-36% -$14.1K ﹤0.01% 317
2018
Q1
$42K Sell
556
-100
-15% -$7.95K ﹤0.01% 273
2017
Q4
$47K Hold
656
﹤0.01% 262
2017
Q3
$53K Sell
656
-50
-7% -$3.82K 0.01% 216
2017
Q2
$50K Buy
706
+50
+8% +$3.33K 0.01% 221
2017
Q1
$45K Hold
656
0.01% 220
2016
Q4
$47K Buy
656
+600
+1,071% +$44.6K 0.01% 202
2016
Q3
$4K Sell
56
-14
-20% -$1.14K ﹤0.01% 442
2016
Q2
$6K Buy
70
+14
+25% +$1.24K ﹤0.01% 427
2016
Q1
$5K Sell
56
-10
-15% -$902 ﹤0.01% 427
2015
Q4
$7K Buy
66
+10
+18% +$1.04K ﹤0.01% 391
2015
Q3
$5K Hold
56
﹤0.01% 411
2015
Q2
$7K Hold
56
﹤0.01% 371
2015
Q1
$5K Hold
56
﹤0.01% 406
2014
Q4
$5K Hold
56
﹤0.01% 426
2014
Q3
$6K Hold
56
﹤0.01% 420
2014
Q2
$5K Hold
56
﹤0.01% 414
2014
Q1
$4K Hold
56
﹤0.01% 433
2013
Q4
$4K Sell
56
-140
-71% -$9.75K ﹤0.01% 434
2013
Q3
$12K Buy
196
+140
+250% +$8.37K ﹤0.01% 323
2013
Q2
$3K Buy
+56
New +$2.92K ﹤0.01% 422

Other funds holding GILD

QCI Asset Management's GILD Position: Q2 2020 in Review

QCI Asset Management sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 235,992 shares — an estimated $17.6M sold.

QCI Asset Management first reported a position in GILD in Q2 2013 and held it in 28 quarters. The position peaked at $19.2M in Q4 2019. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • QCI Asset Management reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • QCI Asset Management sold 235,992 Gilead Sciences shares in Q2 2020, an estimated $17.6M.
  • QCI Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 28 quarters.
  • QCI Asset Management's Gilead Sciences position peaked at $19.2M in Q4 2019.
  • 1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on QCI Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.